Introduction to Long Term Care Pharmacy DEA Compliance
This post is a follow-up to our previous discussions on Emergency Schedule II Controlled Substance Prescriptions in Long-Term Care Pharmacies (LTC pharmacies) and Long-Term Care Facilities (LTCFs). Today, we’re tackling another critical compliance issue that often leads to DEA violations and civil fines: Emergency Dispensing Kits (EDKs). This article only applies to controlled substances that are listed in Schedules II-V of the CSA.
EDKs are widely used in LTC settings to ensure timely access to medications during emergencies. However, their regulatory status under DEA rules is complex, and frequently misunderstood. Missteps here can cost pharmacies thousands of dollars in fines and jeopardize their DEA registration.
It’s important to understand that EDKs are not specifically mentioned or authorized under DEA regulations, they are authorized under a statement of policy published in April of 1980. Before using them, ensure full compliance with all applicable state requirements.
The DEA has provided limited guidance and regulations regarding Emergency Dispensing Kits (EDKs). Below are some resources you can review to gain a better understanding:
- 45 FR 24128, April 9, 1980 – Statement of Policy on EDK Kits
- Notice; Solicitation of Information – Dispensing of Controlled Substances to Residents at Long Term Care Facilities
What Makes EDKs Different?
An Emergency Dispensing Kit is not the same as an Automated Dispensing Machine (ADM) located at a long-term care facility. ADMs have specific DEA guidance and are often treated as separate registered locations. EDKs, on the other hand, are considered an extension of the pharmacy, even though they are physically located in an unregistered LTC facility.
Here’s the catch: DEA regulations do not explicitly authorize EDKs, although a DEA statement of policy written in 1980 does. These kits exist because DEA has allowed them as a practical solution, but they remain unregistered locations where controlled substances are stored. That means the pharmacy bears full responsibility for everything that happens with the controlled substances in a EDK kit.
Key Compliance Considerations for EDKs
Let’s break down the most important rules and best practices:
1. Inventory Requirements
Since EDKs are considered part of the pharmacy, they must be included in your initial and biennial inventory. 21 CFR 1304.11. This means:
- Every EDK kit under your control must be counted on the same day as your pharmacy inventory and included in your pharmacy biennial inventory.
- For LTC pharmacies with kits spread across a large geographic area, this is a logistical challenge—but it’s non-negotiable.
- Failure to include EDK contents in your inventory can result in DEA citations.
Pro Tip: Create a detailed biennial inventory schedule and assign staff to verify counts simultaneously across all locations.
2. Prescription Authorization Before Withdrawal
No one is authorized to withdraw controlled substances from an EDK until:
- The pharmacy has a valid prescription in hand or anEmergency Call in Schedule II Prescription, and
- The pharmacy has authorized the LTC facility to make the withdrawal.
Important way to think of it this: Would you allow someone to pull a controlled substance from behind your pharmacy counter without a prescription? The same principle applies to EDKs.
Compliance Risk: Allowing LTC staff to access EDK drugs without prior pharmacy approval is a major DEA violation.
3. Documentation of Transfers
Although DEA does not require a formal transfer record for EDK stocking, best practice is to maintain a log of what controlled substances were sent to each kit. Why?
- EDKs are not DEA-registered locations, so you cannot use DEA Form 222 for Schedule II transfers.
- A detailed log provides traceability and supports your accountability during audits.
4. Responsibility for Loss or Theft
The pharmacy is fully responsible for any controlled substances stored in EDKs. If drugs go missing or are stolen:
- The pharmacy must report the loss to DEA using Form 106.
- You cannot shift blame to the LTC facility—the DEA views the pharmacy as the custodian.
Action Step: Review our previous blog post on DEA Form 106 reporting for detailed guidance.
5. Emergency Use Only
EDKs are for true emergencies only. That means:
- Withdrawals should never exceed a small amount—just enough to dose the patient one time.
- Using EDKs for routine dispensing or multi-dose withdrawals is in violation of regulations; they are not for general dispensing.
Best Practice: Audit EDK usage monthly to ensure withdrawals align with emergency-only criteria.
6. Pharmacist Corresponding Responsibilities
Pharmacists at Long Term Care pharmacies maintain a corresponding responsibility to ensure that every prescription is issued for a legitimate medical purpose in the usual course of professional practice. This obligation applies to all controlled substances dispensed from an Emergency Dispensing Kit (EDK). Meeting this requirement can be challenging when the EDK is located outside the pharmacy.
Why EDK Compliance Is So Challenging
The biggest hurdles for LTC pharmacies include:
- Geographic Spread: Coordinating inventory across multiple facilities on the same day.
- Staff Training: Ensuring LTC staff understand that EDK access requires prior pharmacy authorization, via a valid prescription.
- Documentation Gaps: Many pharmacies fail to maintain adequate logs for EDK stocking and withdrawals.
- Incident Reporting: Delays in reporting theft or loss can escalate penalties.
- DEA Inspections: If a DEA Diversion Investigator conducts an unannounced inspection of an EDK at a LTCF, it can be challenging to assist and sign the DEA Form 82 (Notice of Inspection). Although the LTCF itself is not a DEA registrant, the EDK—considered an extension of the pharmacy—remains subject to DEA inspection.
Consequences of Non-Compliance
DEA violations related to EDKs can result in:
- Civil fines (often thousands of dollars per violation)
- Increased audit scrutiny
- Potential suspension or revocation of DEA registration
- DEA could require you to remove the EDK from the LTCF
Given the stakes, proactive compliance is essential.
Best Practices for EDK Compliance
Here’s a quick checklist to keep your pharmacy on track:
- Include EDKs in Biennial Inventory: Schedule and verify counts across all kits on the same day.
- Require Prescription Before Withdrawal: No exceptions.
- Maintain Stocking Logs: Document every controlled substance sent to an EDK.
- Monitor Usage: Ensure withdrawals are for emergencies only, and quantities are minimal.
- Report Losses Promptly: File DEA Form 106 for any theft or significant loss.
- Train LTC Staff: Provide written protocols and conduct periodic compliance reviews.
Building a Compliance Culture
Compliance isn’t just about avoiding fines—it’s about patient safety and professional integrity. Pharmacies should:
- Develop clear SOPs for EDK management.
- Conduct regular audits and mock DEA inspections of each EDK.
- Use technology (inventory management systems, secure access controls) to strengthen oversight.
- Communicate expectations to LTC partners and document training.
Final Thoughts
Emergency Dispensing Kits fill a critical need in long-term care, but they come with significant compliance responsibilities. Treat every EDK as if it were behind your pharmacy counter, because in the eyes of the DEA, it is.
If you’re unsure whether your EDK practices meet DEA standards, now is the time to act. A proactive compliance review can save your pharmacy from costly penalties and protect your DEA registration.
Need Expert Guidance and Help?
Brinks DEA Consulting specializes in helping LTC pharmacies navigate complex DEA regulations. We offer:
- EDK compliance audits
- SOP development
- Staff training programs
- Mock DEA inspections
Contact us today:
📧 scott@sbrinksconsulting.com
📞 216-313-8191